Search
Products
Community
Markets
News
Brokers
More
EN
Get started
Community
/
Ideas
/
$ABCL a favorite long term but risk ahead
AbCellera Biologics Inc.
$ABCL a favorite long term but risk ahead
By ClassicEquity
Follow
Follow
Feb 11, 2023
0
Feb 11, 2023
ABCL
a favorite long term but risk ahead if markets falter as revenue from Covid treatment stops coming in
biotech
Fundamental Analysis
Trend Analysis
ClassicEquity
Follow
Also on:
Disclaimer
The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the
Terms of Use
.